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ABSTRACT
Trypanosoma brucei, the African trypanosome, is an organism heavily dependent on
glucose for ATP production during the infectious stage of its life cycle. Here, we have explored
the role of an uncharacterized protein designated “novel glucose transporter” (NGT) as a
potential glucose transporter. Sequence analyses suggests that NGT shares similarities (either at
the primary sequence level or structurally) with Trypanosome Hexose Transporters 1 (TbTHT1),
and human GLUT3, both of which are membrane sugar transporters. NGT was localized by
fluorescence microscopy to subcellular structures consistent with lysosomes. Silencing NGT
expression with RNA interference in parasites resulted in a growth defect in high glucose media,
but not in low glucose media. Further genetic manipulation, to generate cells with single copy
NGT disruptions, led to altered binding of the lectin concanavalin A to EP procyclin when
compared to the parental cell line. To summarize, NGT, a protein with similarities to known
sugar transporters, localizes near the lysosome, and interference with NGT expression plays a
role in viability in high glucose media and alters parasite surface molecules glycosylation or
expression.
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CHAPTER ONE
NEW GLUCOSE TRANSPORTER
Introduction
Human African Trypanosomiasis (HAT) is a disease that threatens 60 million people. Its
animal counterpart, nagana, is economically devasting to the livestock of these same people.
Both diseases are caused by Trypanosoma brucei. Despite its human and economic impact, there
is a shortage of effective treatments for trypanosome infections, particularly of animals (Beard,
2009; Bringaud & Baltz, 1993). T. brucei belongs to a larger classification of parasite known as
kinetoplastids. A common feature among vertebrate-infecting kinetoplastids is that they are
spread by biting flies. T. brucei spends a part of its life cycle in the blood stream of mammals
where glucose is abundant (~5 mM), and the rest of its life cycle in the tsetse fly. The blood
stream form (BSF) of T. brucei relies on glucose for ATP production and does not metabolize
other carbon sources. Because of this, the discovery of glucose uptake pathways is a crucial step
towards understanding the metabolic processes of T. brucei in its infective stages (Bringaud &
Baltz, 1993; Chambers et al., 2008). The procyclic form (PF) of T. brucei lives in the usually low
glucose environment of the tsetse fly midgut and relies on alternative metabolic strategies to
fulfill energy demands of the BSF because of this difference of environment.
One of the key difficulties in combatting T. brucei is their ability to avoid host immune
responses. Variant surface glycoproteins (VSGs), for example, help T. brucei to evade host
antibody-mediated immune responses and render vaccination against T. brucei impractical. In
addition, current treatments of HAT, such as suramin, are losing efficacy over time, as resistance
is selected for in the parasite, and many of the anti-trypanosomals are noted for their toxicity
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(Wiedemar et al., 2018). New drug development combats this challenge by introducing new
agents with potentially unique modes of action. Investigating the proteins involved in glucose
uptake and metabolism could lead to the identification of promising therapeutic targets for new
drug development.
In T. brucei, there are two types of described hexose transporters, TbHT1 and TbHT2.
The expression of these transporters changes based on the life cycle stage of the parasite. The
difference between the two T. brucei hexose transporters reflects the role each one plays in
glucose uptake. TbHT1 is primarily expressed in the BSF infectious stage of the life cycle. Since,
this is a high glucose environment, TbHT1 kinetic parameters reflect the glucose abundance,
being low-affinity, high-capacity glucose transporters. In contrast, TbHT2 is a high-affinity, but
low-capacity transporter that is expressed in PF parasites. This allows the cell to take advantage
of the limited glucose available in the tsetse fly while in the PF lifecycle stage (Landfear, 2011).
TbHT1 and TbHT2 are representatives of multigene families. There are six tandem
copies of TbHT1 followed by five copies of TbHT2. These genes are transcribed together into
polycistronic mRNA before maturation into monocistronic mRNA fragments for translation
(Bringaud & Baltz, 1994). Once a large multigene mRNA has been transcribed, it is then
separated into individual genes through trans splicing. Gene expression in T. brucei is regulated
post transcriptionally, with RNA stability and turnover being influenced by regulatory RNA
binding proteins. Elements in throughout the gene, such as the 3’ untranslated region, influences
the RNA binding proteins. Additionally, the UTRs can influence stability of transcripts. For
example the 5’ cap protects spliced mRNA from degradation while promoting binding of
translation machinery to the mRNA. Without this 5’ cap, spliced mRNAs are quickly degraded,
and thus not translated (Laird et al., 1985; Borst, 2016; Ignatochkina et al., 2015).
2

A novel protein, designated New Glucose Transporter (NGT) (Qiu, unpublished), has
shown sequence similarity to both TbTHT, and human GLUT3. GLUT3 is one of the two types
of glucose transporters found in humans. While the Na+-glucose linked transporters (SGLT) use
sodium as a symporter to couple with glucose transport, the facilitative glucose transporters
(GLUT) rely on facilitated diffusion to transport glucose. GLUT transporters are divided into
three classes based on sequence similarity,: GLUT 1, 2 and 3. Common features of GLUT
proteins regardless of class include the presence of 12 transmembrane domains, a conserved Nlinked glycan, and a large cytoplasmic linker domain. Most GLUT proteins are capable of
transporting glucose or other sugars that fit into the broader category of hexoses (Scheepers et
al., 2004; Thorens & Mueckler, 2014).
GLUT3, the protein with similarity to NGT, is a glucose transporting protein coded for
by the SLC2A3 gene. It is the class 1 GLUT protein in humans with the highest maximum
affinity and turnover for glucose. The primary role of GLUT3 is glucose uptake in neurons.
GLUT3 plays additional roles in some species. For example, GLUT3 has a role in mouse
embryonic development and is found in sperm flagellum in murine species (Thorens &
Mueckler, 2014).
The form and function of different sugar transporters varies based on the unique needs of
the cellular environments. Blood stream-dwelling parasites, such as African trypanosomes and
malaria, live in a glucose rich environment, while parasites, such as Leishmania parasites in
macrophages, reside in glucose poor environments. These different niches require the use of
different mechanisms for glucose uptake and regulation (Landfear, 2011).
In other kinetoplastids, for example Leishmania, the glucose requirements for infectious
and vector born lifecycle stages are reversed when compared to T. brucei, with the mammalian
3

infectious form living in a glucose depleted environment while the insect vector niche has more
abundant available glucose. In the vertebrate host, the amastigote form inhabits macrophage
phagolysosomes where glucose is scarce. Despite the scarcity of glucose in phagolysosomes, it is
likely that amastigotes are still dependent on glucose for survival (Landfear, 2011). The insectform promastigote primarily resides in the gut of the sand fly vector and occupies a niche where
sugar is abundant.
Leishmania species have three known hexose transporters (GT1, GT2, and GT3) which
belong to the GLUT family of transporters (Feng et al., 2013, 2018). Mutant promastigotes that
lack all three genes have been generated, and these cells were unable to import four different
hexoses: glucose, fructose, mannose, and galactose. Additionally, these null mutants grew more
slowly than parental lines when using proline as an alternative carbon source. This alternative
carbon source would also be available to the parasite in the sandfly gut, providing nutrition to the
parasite when glucose was depleted by the fly following feeding. In contrast, intracellular
amastigote null mutants were not viable. This indicates a dependence on hexoses in the
amastigote stage, even though phagolysosomes are noted for having low sugar concentrations
(Feng et al., 2013; Landfear, 2011).
When each of these three hexose transporters were individually restored by
complementation in the null mutant background, GT1 and GT2 were not able to restore
amastigote intracellular viability. However, GT3 expression rescued intracellular amastigotes
viability. GT3 is an ER-resident transporter in amastigotes and it is likely that it transports
glucose for glutamate production rather than serving as a carbon source for ATP production
(Feng et al., 2018).
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Here, the structure of the African trypanosome NGT, as well as on the impact of
modulating its expression on cell viability are explored. We have found that NGT shares
sequence and predicted structural features with other hexose transporters and that lower
expression of NGT has a negative effect on cell proliferation in high glucose environments.
Additionally, our localization studies suggest that NGT may reside in the endocytic pathway,
possibly in the lysosome. This is different from other described T. brucei glucose transporters
that are plasma membrane proteins.

Materials and Methods

Culturing and transfection of trypanosomes
Procyclic form T. brucei 29-13 cells, a modified 427 strain expressing a T7 RNA polymerase
and a tetracycline repressor, were grown in SDM79 or SDM79Ө, the low glucose media (~5 µM
glucose) (Crowe et al., 2020). Cell numbers were monitored using a hemocytometer. For
transfections, 20 µg of DNA were linearized and electroporated (Bio-Rad GenePulser Xcell;
exponential, 1.5 kv, 25 µF) in 4mm cuvettes. Twenty-four hours post electroporation, the
appropriate drug was added to the cell culture for selection.

Fluorescence microscopy
PF 29-13 cells grown in SDM79 were transfected with the vector pXS6.QB expressing NGT
with an eYFP tag on the C terminus. Cells (1 x 107) were harvested by centrifugation (800 x g,
5

10 min) and the pellet resuspended in 500 mLs modified PBS (mPBS) [137 mM NaCl, 3 mM
KCl, 16 mM Na2HPO4, 3 mM KH2PO4, 46 mM sucrose, and 10 mM glucose (pH 7.6)] (Lin et
al., 2013) and incubated with 100 μg/mL Texas Red Dextran (Life Technologies, Fredrick
Maryland) at room temperature for up to 45 minutes. Samples were taken at 15 min intervals and
washed with mPBS before being placed on slides for live cell imaging. Images were captured on
a Leica LMi8 immediately after slide preparation.

Growth of NGT RNAi PF cell lines
PF 29-13 cells grown in SMD79, a high glucose media, were transfected with the vector pZJM
(Wang et al., 2000) expressing a short, double-stranded RNA sequence from NGT (NGT 97-366,
where 1 is the A of the initiating methionine). The RNAi cells were compared to the parental
cells, as leaky (unintentional) expression of dsRNA in the RNAi line is well described and can
impact cell growth rates. Both parental and RNAi cell lines were also acclimated to SDM79Ө, a
low glucose media.
Each of these cell lines was seeded at 105/mL, tetracycline (1 µg/mL) added to the RNAi
line (note, this low level does not impact parental cell growth at) and grown for 10 days. Each
replicate was maintained in 3 mL of media. Cells were counted every 24 hr on a hemocytometer.
Cells were passed back to 105/mL each time their density reached 107/mL to keep cell density
from affecting growth rates. Growth experiments were performed in triplicate and the mean and
the standard deviations were calculated.

Generation of NGT knockout PF cells lines
6

The goal of this experiment was to use CRISPR-Cas9 to insert a stop codon along with the
blasticidin resistance gene (BlaR, D83710) into the coding region of the NGT open reading
frame. This was done in 29-13 procyclic T. brucei cells that express Staphylococcus aureus Cas9
from the vector pLEW111v5. To design the gRNA, the Eukaryotic Pathogens CRISPR guide
RNA/DNA Design Tool was used (http://grna.ctegd.uga.edu/) and the resulting guide sequence
(GCTGGTCGCCAAACCGTTGGAGG) corresponding to nucleotides 42-64 of the NGT ORF
(where 1 is the first nucleotide of the initiating methionine) was cloned into the vector pT7
(pT7sgRNA, Supp. Fig. 1) upstream of the SaCas9 scaffold sequence (Rico et al., 2018). Using
PCR, the portion of the plasmid containing the T7 promoter and gRNA/scaffold sequence was
amplified to generate 20 µg of linear DNA for transfection into the 29-13 cells. The PCR product
was concentrated and cleaned up by ethanol precipitation (Shaw et al., 2020).
The repair template was designed to include 30 bp homology arms flanking the BlaR
gene. These homology arm sequences correspond to the region directly up and downstream of
the gRNA cut site. The fusion repair template was generated by PCR amplification of BlaR. (See
supplemental Table 1 for primer sequences.) This PCR product was concentrated and cleaned up
by ethanol precipitation prior to transfection (Rico et al., 2018).
Next, tetracycline (1 µg/mL) was added to 1 x 107 cells of 29-13 pLEWCas9 in SDM79
to induce Cas9 production. These cells were transfected 24 hr later with the gRNA and the repair
template. Twenty-four hours post transfection, blasticidin (10 µg/mL) was added to select for
cells that had incorporated the repair template containing BlaR (Rico et al., 2018; Shaw et al.,
2020).
Once blasticidin resistant cells were generated, PCR was used to confirm disruption of
NGT using a set of primers that amplified the modified region for comparison to the parental line
7

(Sup. Table 1 primer seq.). The NGT knockout culture likely contained a mixture single copy
and double copy disruptions. To isolate individual clonal cells for testing, the culture was diluted
to ½ cell per 100 µL of media and grown in 100 µL in a 96 well plate.

FITC Concanavalin-A staining
Glycosylation of PF parasite surface proteins was compared using FITC conjugated
concanavalin-A. This lectin binds to EP-procyclin, a glycoprotein, and has been found to be a
useful tool for assessment of PF surface molecule expression (Acosta-Serrano et al., 2000;
Hackler et al., 2015). PF cells (1 x 106) of 29-13 NGT knockout subclones 1, 2, and 3, 29-13
pZJM NGT, and their parental cell lines were pelleted and resuspended in 200 uL cytomix after
being washed once with 1 X PBS. Aliquots (100 µL) of each of these were separated as negative
controls and 100 uL of no FITC control was added. FITC-ConA (20 µg/mL) was added to the
remaining samples. Cells were immediately analyzed on a Beckman Coulter CytoFLEX
(Indianapolis, IN) with data assessed using FCS Express (Insightful Science, San Diego CA).

Results
NGT Shares Similarity with TbTHT1 and GLUT3
The NGT amino acid sequence (Tb427.04.2290-t26_1) was aligned with a known T.
brucei glucose transporter, THT1 (Fig. 1.1). The sequence identity was 186/518 (36%), and
sequence positives were 280/518 (54%). Sequence identity represents amino acids that match,
while sequence positives represent amino acids that match as well as amino acids that are
8

chemically and/or structurally similar. This finding suggests that NGT could be a glucose
transporter. To further explore this, we modeled the predicted NGT structure against a database
of proteins with known structures. The NGT amino acid sequence was modelled using SWISSMODEL (Benkert et al, 2011; Bertoni et al, 2017; Bienert et al, 2017; Guex et al, 2009; Mariani
et al, 2013; Struder et al, 2020; Struder et al, 2021; Waterhouse et al, 2018). The alignment
generated was based on human GLUT3 (4zwc.1.A), a facilitated glucose transporter (Fig. 1.2).
GLUT3 is a membrane glucose transporter with the highest maximum glucose affinity and
turnover in class I of the GLUT family (Thorens & Mueckler, 2014). If NGT is functionally
similar to GLUT3, this suggests that NGT operates in a high glucose environment where high
glucose turnover is necessary. Both proteins share features (predicted for NGT), including 13
alpha helixes, 12 of which line a membrane. These 12 membrane-spanning regions are the
portions of the model with greatest predicted confidence, which is represented by a darker color
for these regions (Fig. 1.2). The portions of the protein that exist outside of the membrane have
the lowest predicted confidence. This model alignment supports the possibility that NGT could
be a membrane glucose transporter and led us to further explore the function of this protein.

NGT Localizes Internally, Near the Lysosome.
To assess the subcellular localization of NGT, procyclic form 29-13 cells were
transfected with the expression vector pXS6Q (Qiu, unpublished data) containing the NGT
coding sequence in frame with a C-terminal eYFP fusion partner. The fluorescent protein, when
visualized by microscopy did not localize to the plasma membrane, as is found with other known
T. brucei glucose transporters (Kovarova et al., 2018), instead, NGT localized internally and in
particular regions of the cell (Fig. 1.3). To further refine the localization, we incubated cells with
Texas Red Dextran (TR-Dex), which cells take up by endocytosis and deliver through the
9

endocytic pathway to the lysosome (Sheng et al., 2013). Co-localization of fluorescent NGT with
the TR-Dex suggested that NGT localized in the same region of the cell as the lysosomal marker
(Fig. 1.3).

NGT RNAi Causes a Significant Growth Defect in Parasites in High Glucose Media, but Not in
Trypanosomes in Low Glucose Media
Because of the potential of NGT being a glucose transporter, we tested the impact of
altered expression of NGT on cell viability in both high and low glucose media, using inducible
RNAi to silence gene expression in T. brucei. To initiate silencing, tetracycline was added to
cultures of T. brucei harboring pZJM-NGT and cells were counted daily. In SDM79 (glucose
rich medium), the NGT RNAi cell line grew significantly slower than the parentals (P<0.05)
with a maximum difference in cell density of 75.4% on day 9 (Note, induced cells to uninduced
were not compared, as uninduced “leaky” expression of dsRNA is a well-described phenomena
in the RNAi system in trypanosomes (Wang et al., 2000).) Growth rates were only significantly
different for days 1-3 in the cells grown in SDM79ϴ (low glucose media). While the graph
shows a greater difference between parental and RNAi cell lines on days 5-10, variation in
growth rates of individual replicates increased as time went on as well, which caused the
differences to not be significant (P>0.05). These results suggest that NGT is more important to
the parasites in high glucose media (SDM79) than in low glucose media. Thus, future
experiments focused on cells grown in high glucose media.

Generation of a Single Copy Knockout of NGT
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RNAi never eliminates gene expression, and without an NGT specific antibody, we could
not determine how much gene expression was decreased. To counter this, we developed a more
complete ablation of the gene using CRISPR-Cas9 technology, to edit the gene and ablate NGT,
PF parasites expressing saCas9 were transfected with gRNA specific to NGT. Additionally, a
repair template harboring a selectable marker (blasticidin resistance) was included. Once a
culture survived both transfection and selection, gDNA was extracted for testing by PCR. These
PCR tests used primers that either required the presence of the integrated repair template or
produced different size amplicons if the repair template was correctly integrated (Fig. 1.5A).
Using the primer pair F.HomoA and R.NGT657 (which produces a ~700 bp fragment in wt, and
a ~ 1100 bp fragment in the disrupted gene), we found production of both bands (Fig. 1.5B).
Using the primer pair F.BlaR and R.NGT657 (which produces no band in wt, and ~ 1050 bp in
disrupted gene), we found a ~1050 bp band in the CRISPR-Cas9 modified culture, and four
bands of various sizes in the parentals (Fig. 1.5B). This was not expected, so an additional test
with the primer pair F.HomoA and R.BlaR (which generates no band in wt, and ~500 bp in the
disrupted gene) was done, we found a band at ~500 bp in the CRISPR-Cas9 modified culture,
and no band in the parental culture (Fig. 1.5B). Based on these tests, we concluded that culture
generated by the CRISPR-Cas9 transfection produced both modified copies of NGT DNA and
unedited copies of NGT DNA (Fig. 5B), but it was not possible to determine if this was from a
mixture of double copy knockout, single copy knockout, and no knockout cells, or all single
copy knockouts. Thus, the cell culture was diluted and allowed to grow to isolate clonal cultures.
These clones were tested with the primer pair F.NGT and R.NGT657 (which should produce a
~750 bp band in wt, and ~1150 bp band in the disrupted gene). We found both the bands for the
disrupted gene and the unmodified gene in the single cell isolated cultures (Fig. 1.5C). This
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showed that the single cell isolated culture contained both modified and unmodified copies of
NGT in their genome and were thus considered single copy, or partial, knockouts (PKO).

Decreased NGT Expression Leads to Altered Lectin Binding
Manipulation of glucose in vitro can cause changes in PF surface molecule expression
(Vassella et al., 2004; Parodi, 1993) and these changes can be monitored by lectin binding. We
hypothesized that parasites deficient in NGT might have an altered surface molecule phenotype.
To assess this, we used the lectin concanavalin A (ConA) which is known to bind the major
surface glycoprotein EP-procyclin (Acosta-Serrano et al., 2000). When cell lines stained with
lectin that had NGT silenced were compared to parental lines, this would indicate if ablating
NGT had an impact on surface molecule expression. Using flow cytometry the RNAi cell line
bound more ConA when compared to parental parasites (Fig. 1.6A). In the NGT KO cell lines
(Fig. 1.6B), the increase in fluorescence was even greater than in the RNAi cell line, perhaps due
to greater disruption of NGT expression. Overall, these results suggest that as NGT expression is
reduced, surface glycoprotein expression, or glycosylation, increases.

Discussion
Before the initiation of the work described in this thesis, NGT was an uncharacterized
gene in T. brucei. Our experiments demonstrate that modulation of NGT expression influences
PF T. brucei proliferation in a high glucose environment. Fluorescent NGT is also shown to
localize internally, near the acidic lysosomes. Finally, reduction of NGT expression altered lectin
binding to the parasite.
12

NGT has sequence similarity with TbTHT1, as well as predicted structural similarity to
human GLUT3, both of which are characterized as glucose transporters. The suggested structural
similarities indicate that, based on sequence, NGT could be a glucose transporter spanning a
membrane (Fig. 1.1; Fig. 1.2). Adding on to that, both TbTHT1 and GLUT3 are high-capacity
glucose transporters, a characteristic useful in high glucose environments (Bringaud & Baltz,
1994; Thorens & Mueckler, 2014). This suggests that NGT may be expressed more in a high
glucose environment.
Since so little is known of NGT, we wanted to see where in the cell NGT localizes and is
expressed. To do this, an eYFP tag was added to the C-terminus of NGT in the pXS6.Q (Qui,
unpublished) expression vector. This caused the trypanosomes to constitutively express a
fluorescent version of NGT which could then be visualized by microscopy (Fig. 1.3). We
determined that NGT localized internally, rather than on the plasma membrane, as other T.
brucei glucose transporters do (Kovarova et al., 2018). This led us to ask why would a glucose
transporter internally localize?
In Leishmania, one of three identified glucose transporters, GT3, resides in the
endoplasmic reticulum, another internal localization and is a part of the endocytic uptake
pathway. This protein is the only required glucose transporter in the amastigote stage.
Amastigotes reside intracellularly in host macrophages, an environment which is very low in
glucose (Feng et al., 2014). The question then became, does NGT perform a similar function in
T. brucei as GT3 does in Leishmania?
This was first addressed by incubating the parasite that expresses fluorescent NGT with
TR-Dex, which enters the cell through endocytosis. TR-Dex fluorescence also increases as the
pH falls, and it has extremely limited fluorescence at neutral pH, which makes it a good
13

lysosome marker (Sheng et al., 2013). Co-localization revealed that NGT resides in a partially
overlapping compartment with TR-Dex (Fig. 1.3), suggesting NGT localizes to the lysosome.
While the role of NGT in the lysosome is unclear, it is possible that the protein plays a role in the
acquisition of environmental glucose from liquid taken up by pinocytosis. Trypanosomes have a
very high rate of endocytosis (Link et al., 2021), so it is likely that large volumes of liquid taken
from the surrounding (host fluids) are therefore ingested. Alternatively, the protein may play a
role in the transport of sugars reclaimed from the recycling of surface molecule proteins like EP
procyclin, which are abundant and decorated by large glycan structures (Acosta-Serrano et al.,
2001; Butikofer et al., 1997).
Because of the potential for NGT being a glucose transporter, we inhibited NGT
expression in both high and low glucose environments and compared cell growth to parental cell
lines (Fig. 1.4). Depletion of NGT produced a significantly reduced growth in a high glucose
media but did not produce a significant difference in growth rates in a low glucose media. This
further supports the idea that NGT function is related to glucose, as that is the key difference
between SDM79, and SDM79ϴ, the two medias that were used (Crowe et al., 2020). This
suggests that NGT has a functional difference from GT3, as GT3 is most important in low
glucose environments (Feng et al., 2014).
Since RNAi does not completely ablate protein expression and the amount of ablation
cannot be directly measured without an NGT specific antibody (which has not been developed),
we wanted to generate knockouts of NGT to use for testing the effects of NGT elimination on T.
brucei. To do this, CRISPR-Cas9 was used to integrate the BlaR resistance gene into the coding
sequence of NGT. We were able to obtain cells containing a partial knockout of NGT (Fig. 1.5)
bearing single copy disruptions. These PKOs, as well as the NGT RNAi cell lines, were
14

compared to parental 2913 cells by FITC-ConA staining. ConA binds to the glycosylated surface
protein EP-procyclin (Acosta-Serrano et al., 2000), and the FITC tag allows fluorescent detection
of that interaction. In the case of cells with altered NGT compared to unmodified cells, reduction
of NGT caused an increase in fluorescence. This could result for several reasons, including an
increase in glycosylation of surface proteins or an increase in EP procyclin expression.
It is only possible, at this stage, to speculate on why NGT ablation leads to changes in
ConA binding. If NGT is a glucose transporter, why would disrupting NGT expression lead to
increased glycosylation or EP procyclin expression? It is possible that when there are less
general glycans on the surface of the cell, more EP procyclin molecules are expressed to fill the
gaps made by fewer glycans per protein that could result from partially glycosylated EP
procyclins. Alternatively, NGT ablation may lead to misregulation of metabolism in a way that
generates more glycans. If this is the case, NGT may be involved in glucose perception, and
reduced perception of glucose causes the cell to bind more glycans to surface proteins to
compensate. This could suggest a regulatory role for NGT that may have a detectable pathway
that can be disrupted.
In summary, NGT shares some commonalities with TbTHT1, GLUT3, and GT3. First,
NGT and GT3 share a localization distinct from the other glucose transporters that are typically
functional on the plasma membrane (Feng et al., 2018). Secondly, NGT ablation has a greater
impact in a high glucose media, more similar to TbTHT1 and GLUT3 (Kovarova et al,. 2018;
Thorens & Mueckler, 2014).
There are some experiments that could be conducted to build on what is presented here
and continue to characterize NGT. First, generation of a double copy knockout of NGT would
allow for a much clearer view of how the cell functions and survives without NGT. Developing
15

an NGT specific antibody would allow for directly testing NGT expression levels, whether in
unmodified cells, or various NGT ablating cell lines. Furthermore, expressing NGT in an
otherwise glucose transporter deficient system would provide direct evidence of NGT’s glucose
transporting capacity or lack thereof. Discovering the precise cause of the increase in ConA
binding with reduced expression of NGT could provide clues to NGT function. This could be
done by measuring EP procyclin abundance with a specific antibody as NGT expression is
decreased, and by assessing the changes to N-glycans on the cell under the same circumstances.
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Figures:

Figure 1.1: Amino acid alignment between NGT and THT1. Sequences for THT1 and NGT were
aligned using composition matrix adjustment on ClustalΩ. (*) Amino acids match (:) Amino acids
have similar chemical properties and shape (.) Amino acids have similar chemical properties or
shape
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Figure 1.2: SWISS-MODEL of NGT. A model of the NGT structure was generated using SWISS-MODEL. NGT
sequence similarity and alignment with human GLUT3, a facilitated membrane glucose transporter (A). Side view of
the 3D model of GLUT3 (B). Top/bottom view of the 3D model of GLUT3 (C).
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Figure 1.3: Localization by microscopy of fluorescent NGT and Texas-Red
Dextran. Localization of NGT in PF parasites. Transgenic PF 29-13 expressing eYFP
NGT from pXS6Q were incubated with Texas-Red Dextran and visualized by
microscopy.
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B

Figure 1.4: A Growth Curve with NGT RNAi Each PF cell line
includes data from three replicates averaged here with standard
deviation and significance indicated. They were grown in SDM79
media (A) and SDM79Ө media (B). All replicates were maintained in
the same volume of media (3 mL).
( * ) = P < 0.05
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A

Figure 1.5: PCR confirmation of repair template integration into NGT from CRISPR-Cas9: A series of PCR
amplifications using different primers specific to the repair template and NGT (A) were performed on the gDNA of
the original CRISPR-Cas9 transfection culture compared to parental cell gDNA (B) and a confirmation test on single
cell isolated cultures (C) to determine whether the integration was on a single copy, or both copies of NGT.
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Figure 1.6: A cytoflex count of FITC-conA stained NGT RNAi and NGT PKO cells Fluorescent events of
stained 2913 procyclic pZJM NGT cells compared to stained and unstained parental cells (PF 2913s) (A).
Fluorescent events of stained 2913 procyclic NGT PKO cell lines compared to stained and unstained parental cells
(PF 2913s) (B). Samples were prepped immediately before measurement, and 10000 events were measured of
each sample.
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CHAPTER TWO
CONCLUSION
The goal of this thesis was to begin to characterize NGT. A combination of sequence and
structural comparisons suggested that NGT could be a membrane glucose transporter (Fig. 1.1 &
1.2). Subsequent experiments worked to test this hypothesis.
Fluorescent NGT was shown to localize near the lysosome (Fig. 1.3), which differs from
the two surface-expressed glucose transporters (TbTHT1 and human GLUT3); but is not
unprecedented in kinetoplastids as GT3, a glucose transporter in Leishmania, has been localized
to the ER (Feng et al., 2018). However, reduction of NGT expression by RNAi was also shown
to have a negative impact on cell proliferation in high glucose media (SDM79); but not in low
glucose media (SDM79ϴ) (Fig. 1.4), which differs from GT3; and is more similar to TbTHT1
and human GLUT3 (Thorens & Mueckler, 2014; Bringaud & Baltz, 1994). Reduction of NGT
expression also increased binding of the lectin concanavalin A to EP procyclin (Fig. 1.6).
Disruption of a single NGT copy had a greater effect on this than NGT RNAi. These results have
helped refine which questions should be asked next about NGT.
There are several experiments that can be done to build on the work presented here.
Generation of a double copy knockout of NGT would allow for observation of the effects of
complete elimination of NGT expression on the cell. If successful, we will know that NGT is not
essential and we will be able to observe the effects of complete NGT ablation in high and low
glucose environments. However, if NGT is an essential gene, knocking out both copies of the
gene would not be trivial to achieve, requiring complementation with an inducible, ectopic copy
of the gene. We have a vector for this (pLEW100v5), and this can be pursued as necessary.

23

Reducing NGT expression also impacts lectin binding. This could be because of an
increase in EP procyclin expression, a change in the glycan on EP procyclin that makes the
mannose components (the sugar bound by conA) more accessible to the lectin, or an increase in
glycosylation of the surface molecules. These differences could be resolved using western
blotting and characterization of N-linked glycosylation of the EP procyclins (Hackler et al.,
2015).
It is also important to directly test the ability of NGT to transport glucose. This could be
tested by expressing NGT in an otherwise glucose transporter deficient system. One thing to
consider along with this is the internal localization of NGT. If NGT is not involved in
transporting glucose into the cell, then its expression alone may not affect glucose uptake in a
different system.
Based on the available data, the function of NGT is not immediately clear. However, it is
still possible to speculate on its function for the purpose of guiding future experiments. It is
likely that NGT is involved in glucose metabolism. This could be through direct transport of
glucose, glucose sensing to guide regulation of glucose uptake, or a combination of these two
roles. Based on cellular localization, as well as similarities with multiple membrane glucose
transporters, I suspect that NGT is a membrane spanning protein that allows for glucose to be
transported across internal cellular membranes. I do not think that the projected structural
similarities to GLUT 3 (especially the 12 membrane-spanning alpha helices) can be explained
without a transport function for NGT.
However, the relationship between NGT expression and concanavalin A binding to EP
procyclin is not easily explained if NGT is simply a glucose transporter. If NGT were just a
glucose transporter, I do not think that decreasing NGT expression would lead to altered
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glycosylation of surface molecules, as lower available glucose should cause a shortage of
glycosylation. This would instead suggest that NGT may play a glucose sensing role as well. If
NGT is decreased and thus the cell is not able to detect glucose as efficiently, then the amount of
glucose transported for surface molecule glycosylation may be increased as the apparatus for
transporting it is unaware of how much glucose is being transported. If increased EP procyclin
expression were the cause of the results seen in Figure 6, then NGT may not play a sensory role,
but may instead be indirectly involved in post-translational protein modification.
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APPENDIX A
Supplemental Figures
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Primer Name Sequence
F.HomoA
AAGCGCCGTAAAGAAGCGGCTGGTCGCCAAATGGTCAATATGCCTTTG
R.HomoA
CAAGTTAAGCGGCGCACATTCCTCCAACGGTTAGCCCTCCCACACATA
F.NGTgRNA
AGGG GCTGGTCGCCAAACCGTTGGAGG
R.NGTgRNA
CCTCCAACGGTTTGGCGACCAGC CAAA
R.NGT657
AGTAAGAAAGCGCCCCGCCACC
F.NGT
ATCGATAGCTTGGGTCCCATGGTGAG
F.BlaR
CCCATCGATGGGATGATTGAGGGAAGCAGA
R.BlaR
CCCAAGCTTGGGCTAAGATGATTGCCATAA
Supplemental Table S-1: Primers used for NGT CRISPR-Cas9
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Supplemental Figure S-1: Plasmid map of pT7sgRNA
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APPENDIX B
Additional Experiments
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Figure B-1: Epitope tagging AMPKα by CRISPR-Cas9 The goal of this experiment was to use
CRISPR-Cas9 to insert a C.Myc epitope tag and the blasticidin resistance gene (BlaR, D83710)
into the 5’ UTR and first few base pairs of the coding region of AMP-activated Kinase alpha
subunit (AMPKα). This was done in 29-13 procyclic T. brucei cells that express Staphylococcus
aureus Cas9 from the vector pLEW111v5. To design the gRNA, the Eukaryotic Pathogens
CRISPR guide RNA/DNA Design Tool was used (http://grna.ctegd.uga.edu/) and the resulting
guide sequence (CAAGAGGAAGAAGTGGAGGTGG) corresponded to AMPKα -55 through 34 (Where 1 is the first bp of the initiating methionine) (Shaw et al., 2020). This location for the
cleavage site was chosen to allow targeting the repair template without disrupting gene expression
or modifying the protein unnecessarily. The repair template needed to target the junction of the 5’
UTR and the beginning of the coding region of AMPKα for this reason. For selection and
expression, the repair template would need to contain a selectable marker, a spacer, a start codon
followed by the myc tag, and flanked on both sides by homology arms to target integration into
the gene. Amplifying the repair template took two rounds of PCR, the first one adding a
homology arm and the myc sequence to the BlaR sequence with a αβtubulin UTR as a spacer. The
second PCR used the product from the first as a template and added in the second homology arm,
which would have been too large to attach to the first set of primers. In this way, the repair
template was assembled and amplified before being sterilized and concentrated by ethanol
precipitation. The gRNA was cloned into pT7sgRNA (See Supp. Fig. 1) and amplified along with
the T7 promoter and gRNA scaffold. The PCR product was concentrated and sterilized by ethanol
precipitation (Rico et al., 2018). To prepare the cells for transfection, tetracycline (1 µg/mL) was
added to induce Cas9 expression. Twenty-four hours later, 20 µg of both the gRNA and repair
template were transfected into 107 2913 PF cells. Twenty-four hours later, blasticidin (10 µg/mL)
was added to select for integration of the selectable marker in the repair template.
Once through selection, gDNA from the transfected culture was extracted to test by PCR
for integration of the repair template (B). The primers selected for this test would only generate
bands if the repair template was correctly integrated into the gene (A). The PCR results
demonstrated that the repair template was integrated into at least one copy of AMPKα. The next
step would be to test for myc expression by western blot.
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Figure B-2: Creating the modified Plasmid pXG1.M The goal of this experiment was to
increase the utility of the pXG1 (B) Leishmania expression vector by increasing the number
of restriction sites in the multicloning region. This would increase the ease with which the
plasmid could be modified by restriction digest cloning. This was done by ligating on the
SmaI and BamHI cut sites. The insert (A) was designed with four additional cut sites (PacI,
ClaI, AscI, and BglII) and a spacer region. The spacer region was added as a form of
verification of insert integration (C). The new plasmid was designated pXG1.M.
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